カテゴリ： Grand View Research, 世界, 医療/バイオ

睡眠時無呼吸装置の世界市場：治療機器、診断機器

◆英語タイトル：Sleep Apnea Devices Market Size, Share & Trends Analysis Report By Product [Therapeutic (PAP, Oral, Nasal, Chin), Diagnostic (Respiratory Polygraphs, Actigraph, Polysomnography, Pulse Oximeters)], By Region, 2019 - 2025
◆商品コード：GV9NV111
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2019年6月
◆ページ数：80
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥966,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
当調査レポートでは、睡眠時無呼吸装置の世界市場について調査・分析し、市場動向、製品別（治療機器、診断機器）分析、地域別分析、競合動向などを含め次の構成でお届け致します。

・調査手法及び範囲
・エグゼクティブサマリー
・市場動向
・睡眠時無呼吸装置の世界市場：製品別（治療機器、診断機器）
・睡眠時無呼吸装置の世界市場：地域別
・競合動向
【レポートの概要】

The global sleep apnea devices market size is estimated to be worth USD 12.61 billion by 2025, expanding at a CAGR of 6.8% from 2019 to 2025, according to a report by Grand View Research, Inc. Increasing number of patients suffering from sleep apnea, growing awareness, and treatment rate of these diseases in North America are some of the factors contributing to the revenue growth.

On the basis of product type, the market is categorized into therapeutic and diagnostic devices. Therapeutic device led the market with about 65.06% of revenue share in 2018, due to increased awareness and patient medication adherence in developed markets such as U.S. and Canada and high prevalence of Obstructive Sleep Apnea (OSA). PAP Devices led the therapeutic segment due to higher product adoption and availability and comparative higher patient outcome. The segment is expected to witness a CAGR of 5.1% between 2019 and 2025.

Diagnostic device segment comprises of actigraphs, polysomnography, respiratory polygraphs, and pulse oximeters. Polysomnography devices led the market with 34.88% of revenue share in 2018 and is estimated to witness a CAGR of 7.05% over the forecast period. As there is no gold standard for diagnosis of OSA, polysomnography is one of the most preferred diagnostic tests for sleep apnea. Increase in preference of polysomnography test is expected to drive the market revenue between 2019 and 2025.

Sleep apnea PAP devices have witnessed significant development in terms of design, safety, and efficacy has helped to boost product adoption and patient outcome. Moreover, miniaturization of PAP devices and availability of cheaper brands is expected to fuel growth of the sleep apnea devices market over the forecast period. Some of the key manufactur are BMC Medical Co. Ltd.; GE Healthcare; Fisher & Paykel Healthcare Limited; Curative Medical Inc.; Cadwell Laboratories ResMed; Invacare Corporation; Braebon Medical Corporation; ImThera Medical Inc.; Phillips Respironics; Curative Medical Inc.; Nihon Kohden; and Compumedics Limited.

Further key findings from the report suggest:

• Therapeutic devices segment led the market in 2018, with a revenue of USD 5,302.1 million, due to high prevalence of OSA, increased treatment rate, patient adherence, and availability of technologically advanced products

• Oral devices segment is anticipated to exhibit the fastest CAGR of 11.7% over the forecast period as these products offer higher patient outcome, lower economic burden, and higher treatment adherence due to their smaller size

• Some of the key players operating in the sleep apnea devices market are BMC Medical Co. Ltd.; GE Healthcare; Fisher & Paykel Healthcare Limited; Curative Medical Inc.; Cadwell Laboratories; ResMed; Invacare Corporation; Braebon Medical Corporation; ImThera Medical Inc.; Phillips Respironics; Curative Medical Inc.; Nihon Kohden; and Compumedics Limited

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Sleep Apnea Devices Market Outlook, By Revenue (USD Million)
2.2 Sleep Apnea Devices Market Segment Outlook, By Revenue (USD Million)
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Sleep Apnea Devices Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing prevalence of obstructive sleep apnea in chronic obstructive pulmonary disease (COPD)
3.2.1.2 Increasing prevalence of obesity and diabetes associated with sleep apnea
3.2.2 Market Restraint Analysis
3.2.2.1 High cost of diagnosis and treatment of sleep apnea
3.2.3 Penetration & Growth Prospect Mapping
3.2.4 Industry Analysis – Porter’s
3.2.4.1 Supplier Power
3.2.4.2 Buyer Power
3.2.4.3 Substitution Threat
3.2.4.4 Threat from new entrant
3.2.4.5 Competitive Rivalry
3.2.5 PESTEL Analysis
3.2.5.1 Political Landscape
3.2.5.2 Environmental Landscape
3.2.5.3 Social Landscape
3.2.5.4 Technology Landscape
3.2.5.5 Legal Landscape
3.2.6 Sleep Apnea Patient Pool
3.2.7 Sleep Apnea Devices: Product Adoption Analysis
3.2.8 Sleep Apnea Devices: Supply Chain Analysis
3.2.9 Case Studies (Business Model /Technology Adoption)
Chapter 4 Sleep Apnea Devices Market Estimates & Trend Analysis, by product type
4.1 Sleep Apnea Devices Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
4.2 Product Market Share Analysis, 2018
4.2.1 Therapeutic Devices
4.2.1.1 PAP Devices
4.2.1.2 Oral Devices
4.2.1.3 Nasal Devices
4.2.1.4 Chin Straps
4.2.2 Diagnostic Devices
4.2.2.1 Actigraphs
4.2.2.2 Polysomnography
4.2.2.3 Respiratory Polygraphs
4.2.2.4 Pulse Oximeters
4.3 Therapeutic Devices
4.3.1 PAP Devices
4.3.1.1 Global sleep apnea PAP device market, 2014 – 2025 (USD Million)
4.3 2 Oral Devices
4.3.1.1 Global sleep apnea oral devices market, 2014 – 2025 (USD Million)
4.3.3 Nasal Devices
4.3.1.1 Global sleep apnea nasal devices market, 2014 – 2025 (USD Million)
4.3.4 Chin Straps
4.3.1.1 Global sleep apnea chin straps market, 2014 – 2025 (USD Million)
4.4 Diagnostic Devices
4.4.1 Actigraphs
4.4.1.1 Global sleep apnea actigraphs market, 2014 – 2025 (USD Million)
4.4.2 Polysomnography
4.4.2.1 Global sleep apnea polysomnography market, 2014 – 2025 (USD Million)
4.4.3 Respiratory Polygraphs
4.4.3.1 Global sleep apnea respiratory polygraphs market, 2014 – 2025 (USD Million)
4.4.4 Pulse Oximeters
4.4.4.1 Global sleep apnea pulse oximeters market, 2014 – 2025 (USD Million)
Chapter 5 Sleep apnea devices Market: Regional Estimates & Trend Analysis, by Product
5.1 Regional Market Snapshot
5.2 Regional Market Share and Leading Players, 2018
5.2.1 North America
5.2.2 Europe
5.2.3 Asia Pacific
5.2.4 Latin America
5.2.5 Middle East & Africa
5.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.3.1 North America
5.3.2 Europe
5.3.3 Asia Pacific
5.3.4 Latin America
5.4.5 Middle East & Africa
5.4 Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:
5.4.1 North America
5.4.1.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.2 U.S.
5.4.2.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.3 Canada
5.4.3.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.4 Europe
5.4.4.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.5 UK
5.4.5.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.6 Germany
5.4.6.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.7 Spain
5.4.7.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.8 France
5.4.8.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.9 Italy
5.4.9.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.10 Russia
5.4.10.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.11 Asia Pacific
5.4.11.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.12 China
5.4.12.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.13 Japan
5.4.13.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.14 India
5.4.14.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.15 South Korea
5.4.15.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.16 Singapore
5.4.16.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.17 Australia
5.4.17.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.18 Latin America
5.4.18.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.19 Brazil
5.4.19.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.20 Mexico
5.4.20.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.21 Argentina
5.4.21.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.22 Middle East & Africa (MEA)
5.4.22.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.23 Tunisia
5.4.23.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.24 Egypt
5.4.24.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.25 South Africa
5.4.25.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
Chapter 6 Competitive Landscape
6.1 Company Profiles
6.1.1 BMC Medical Co. Ltd.
6.1.1.1 Company overview
6.1.1.2 Financial Performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic Initiatives
6.2. Braebon Medical Corporation
6.2.1 Company overview
6.2.2 Financial Performance
6.2.3Product benchmarking
6.2.4 Strategic Initiatives
6.3. Carefusion Corp
6.3.1 Company overview
6.3.2 Financial Performance
6.3.3 Product benchmarking
6.3.4 Strategic Initiatives
6.4. Compumedics Limited
6.4.1 Company overview
6.4.2 Financial Performance
6.4.3 Product benchmarking
6.4.4 Strategic Initiatives
6.5. Curative Medical Inc.
6.5.1 Company overview
6.5.2 Financial Performance
6.5.3 Product benchmarking
6.5.4 Strategic Initiatives
6.6. Fisher & Paykel Healthcare
6.6.1 Company overview
6.6.2 Financial Performance
6.6.3 Product benchmarking
6.6.4 Strategic Initiatives
6.7. GE Healthcare
6.7.1 Company overview
6.7.2 Financial Performance
6.7.3 Product benchmarking
6.7.4 Strategic Initiatives
6.8. ImThera Medical Inc.
6.8.1 Company overview
6.8.2 Financial Performance
6.8.3 Product benchmarking
6.8.4 Strategic Initiatives
6.9. Invacare Corporation
6.9.1 Company overview
6.9.2 Financial Performance
6.9.3 Product benchmarking
6.9.4 Strategic Initiatives
6.10. Itamar Medical Ltd.
6.10.1 Company overview
6.10.2 Financial Performance
6.10.2 Product benchmarking
6.10.3 Strategic Initiatives
6.11. Natus Medical Inc.
6.11.1 Company overview
6.11.2 Financial Performance
6.11.3 Product benchmarking
6.11.4 Strategic Initiatives
6.12. Nihon Kohden
6.12.1 Company overview
6.12.2 Financial Performance
6.12.3 Product benchmarking
6.12.4 Strategic Initiatives
6.13. Philips Respironics
6.13.1 Company overview
6.13.2 Financial Performance
6.13.3 Product benchmarking
6.13.4 Strategic Initiatives
6.14. ResMed Inc.
6.14.1 Company overview
6.14.2 Financial Performance
6.14.3 Product benchmarking
6.14.4 Strategic Initiatives
6.15. Somnetics International Inc.
6.15.1 Company overview
6.15.2 Financial Performance
6.15.3 Product benchmarking
6.15.4 Strategic Initiatives
6.16. SOMNOmedics GmbH
6.16.1 Company overview
6.16.2 Financial Performance
6.16.3 Product benchmarking
6.16.4 Strategic Initiatives
6.17. Teleflex Inc.
6.17.1 Company overview
6.17.2 Financial Performance
6.17.3 Product benchmarking
6.17.4 Strategic Initiatives
6.18. Weinmann Medical Devices GmbH & Co. KG.
6.18.1 Company overview
6.18.2 Financial Performance
6.18.3 Product benchmarking
6.18.4 Strategic Initiatives

List of Tables

Table 1 Product pipeline analysis, by stage
Table 2 List of key End-users by region / by product / by country
Table 3 List of key distributors and channel partners
Table 4 List of key customers
Table 5 Competitive dashboard analysis
Table 6 List of key emerging companies/technology disruptors/innovators
Table 7 Supplier ranking
Table 8 Sleep apnea devices market, by type 2014 - 2025 (USD Million)
Table 9 North America sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 10 U.S. sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 11 Canada sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 12 Europe sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 13 UK sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 14 Germany sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 15 Spain sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 16 France sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 17 Italy sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 18 Russia sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 19 Asia Pacific sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 20 Japan sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 21 China sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 22 India sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 23 South Korea sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 24 Singapore sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 25 Australia sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 26 Latin America sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 27 Brazil sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 28 Mexico sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 29 Argentina sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 30 MEA sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 31 Tunisia sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 32 Egypt sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 33 South Africa sleep apnea devices market, by Product type 2014 - 2025 (USD Million)


【レポートのキーワード】

睡眠時無呼吸装置、治療機器、診断機器

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[睡眠時無呼吸装置の世界市場：治療機器、診断機器]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 携帯型ワイヤレス医療機器の世界市場：モニタリング機器、治療機器、診断機器、ウェアラブル医療機器
    MAM-SE-3039 / MarketsandMarkets / 2015年1月6日 / 当調査レポートでは、携帯型ワイヤレス医療機器の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、産業動向、市場シェア分析、技術別分析、構成品別分析、用途別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。...The wireless portable medical device market is expected to grow at a rapid pace due to growing income levels, and increasing prevalence of chronic and lifestyle disorders such as diabetes, respiratory, blood and cardiovascular diseases. A growing population coupled with high income levels and awareness about wellness and fitness are some of the factors driving the market growth. Further, integration of various wireless technologies with portable devices and initiatives from various governments have led rural areas to adopt advanced medical services, thereby boosting the wireless portable medical device industry. An increase in lifestyle diseases is creating the need to focus...
  2. ウェアラブル医療機器の世界市場予測（～2022年）：診断機器、治療機器、スマートウォッチ、パッチ
    MAM-MD-4808 / MarketsandMarkets / 2018年1月23日 / MarketsandMarketsが発行した当調査レポートでは、ウェアラブル医療機器の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、診断機器種類別分析、治療機器種類別分析、用途別分析、種類別分析、ウェアラブル医療機器の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The wearable medical devices market is expected to reach USD 14.41 Billion by 2022 from USD 6.22 Billion in 2017, at a CAGR of 18.3% during the forecast period. Factors such as technological advances in medical devices, increasing penetration of smartphones and growing number of smartphone-based healthcare apps compatible with wearable devices, growing preference for wireless connectivity among healthcare providers, and increasing awareness about physical fitness are driving the growth of this market. The report segments the global wearable medical devices market into type, application, device type, distribution channel, and region. Based on type, the market is further classified into...
  3. 聴能学デバイスの世界市場：補聴器、人工内耳、BAHA / BAHS、診断機器
    GV9NV150 / Grand View Research / 2019年7月 / 当調査レポートでは、聴能学デバイスの世界市場について調査・分析し、市場動向、製品別（補聴器、人工内耳、BAHA / BAHS、診断機器）分析、技術別（デジタル聴覚デバイス、アナログ聴覚デバイス）分析、販売チャンネル別（小売販売、政府購入、電子商取引）分析、地域別分析、競合分析などを含め次の構成でお届け致します。 ・調査手法及び範囲 ・エグゼクティブサマリー ・市場動向 ・聴能学デバイスの世界市場：製品別（補聴器、人工内耳、BAHA / BAHS、診断機器） ・聴能学デバイスの世界市場：技術別（デジタル聴覚デバイス、アナログ聴覚デバイス）...The global audiology devices market size is expected to reach USD 15.5 billion by 2026 registering a CAGR of 5.8%, according to a new report by Grand View Research, Inc. Increasing cases of hearing disorders, especially in geriatric population, rising purchasing capacity, investments in R&D, and government support for better healthcare infrastructure are expected to drive the market over the forecast period. High comfort offered by newly introduced devices, improved connectivity, and better user interface are some of the factors attributing to high usage rate of audiology devices. Better quality of life along with acceptance of digital hearing aids are...
  4. 自己免疫疾患の世界市場：疾患別（限局性、全身性）、診断別（IFA、ELISA、ドットブロット、ラインブロット、凝集反応、二重免疫拡散法、ウエスタンブロッティング、多重イムノアッセイ、その他）、製品別（医薬品、治療・モニター機器、診断機器）、地域別予測
    BZW9JN015 / Bizwit Research & Consulting / 2018年12月31日 / 本資料は、自己免疫疾患の世界市場について調べ、自己免疫疾患の世界規模、市場動向、市場環境、疾患別（限局性、全身性）分析、診断別（IFA、ELISA、ドットブロット、ラインブロット、凝集反応、二重免疫拡散法、ウエスタンブロッティング、多重イムノアッセイ、その他）分析、製品別（医薬品、治療・モニター機器、診断機器）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはAbbott Laboratories、Active Biotech、Eli Lilly、Bristol-Myers Squibb、AstraZeneca plc、Pfizer、Biogen Idec、Lupin Limited、GlaxoSmithKline、Amgen、4SC、F. Hoffmann-La Roche...Global Autoimmune Disease Market to reach USD XX billion by 2025. Global Autoimmune Disease Market valued approximately USD 37.81 billion in 2017 is anticipated to grow with a healthy growth rate of more than 3.82% over the forecast period 2018-2025. The Autoimmune Disease Market is continuously growing in global scenario over the coming years. The major driving factor of global Autoimmune Disease market is increasing incidence of chronic diseases and development of novel biomarkers such as Enbrel & Humira. In addition, improvement in regulatory framework, technological enhancements, and growing government assistance are also some other major factors which propelling the...
  5. 多血小板血漿（PRP）の世界市場分析
    GVIEW70714016 / Grand View Research / 2017年6月5日 / 本調査レポートでは、多血小板血漿（PRP）の世界市場について調査・分析し、多血小板血漿（PRP）の世界市場動向、多血小板血漿（PRP）の世界市場規模、市場予測、セグメント別多血小板血漿（PRP）市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global platelet rich plasma market is expected to reach USD 647.1 million by 2025, according to a new report by Grand View Research, Inc. Growing prevalence of orthopedic diseases and increasing application of PRP in cosmetic surgery is propelling the demand for the market. Platelet-rich plasma has become one of the cutting-edge technologies for a number of medical applications including orthopedics, general surgery, cosmetic surgery, cardiovascular surgery, wound healing, and others. Platelet rich plasma treatments aid in soft tissue healing and reduce the risk of post and preoperative bleeding. As a result, it is considered as one of the...
  6. 腫瘍学に基づくインビボCROの世界市場分析：指示別（血液がん、固形腫瘍）、モデル別（同系モデル、患者由来異種移植片（PDX）、異種移植片）、地域別、セグメント予測、2014-2025
    GVIEW707611 / Grand View Research / 2017年5月26日 / 本調査レポートでは、腫瘍学に基づくインビボCROの世界市場について調査・分析し、腫瘍学に基づくインビボCROの世界市場動向、腫瘍学に基づくインビボCROの世界市場規模、市場予測、セグメント別腫瘍学に基づくインビボCRO市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global oncology based in-vivo CRO market is expected to reach USD 1.5 billion by 2025, according to a new report by Grand View Research, Inc. The use of Contract Research Organization (CRO) oncology services helps the manufacturers/sponsors to provide complete attention on the production capacity and at enhancing their in-house processes.Furthermore, the pressure from the increasing competition due to patent expirations, rapid growth of generics, and introduction of biosimilar equivalents are propelling the pharmaceutical companies to take the aid of such organizations. Hence, it can be predicted that the oncology based in-vivo CRO market may witness lucrative growth over...
  7. 軟組織修復の世界市場分析：縫合、縫合アンカー、組織パッチ、メッシュ
    GVIEW709158 / Grand View Research / 2017年8月 / Grand View Researchが発行した本調査レポートでは、軟組織修復の世界市場について調査・分析し、軟組織修復の世界市場動向、軟組織修復の世界市場規模、市場予測、セグメント別軟組織修復市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global soft tissue repair market is expected to reach USD 10.73 billion by 2025, according to a new report by Grand View Research, Inc. Growing number of trauma patients and orthopedic surgeries is one of the key factors expected to drive revenue growth in coming few years. Soft tissue comprises of muscles, ligaments, tendons, fibrous tissue, skin, synovial membranes, nerves and others which protect organs, enable movement and support bones in the body. Injury to the soft tissues can cause severe pain and also may stop movement of the bones, which if left untreated can lead to chronic pain....
  8. 嚢胞性線維症（CF）治療の世界市場分析
    GVIEW70714001 / Grand View Research / 2017年6月2日 / 本調査レポートでは、嚢胞性線維症（CF）治療の世界市場について調査・分析し、嚢胞性線維症（CF）治療の世界市場動向、嚢胞性線維症（CF）治療の世界市場規模、市場予測、セグメント別嚢胞性線維症（CF）治療市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global cystic fibrosis therapeutics market is expected to reach USD 13.9 billion by 2025, according to a new report by Grand View Research, Inc. The rising prevalence of Cystic Fibrosis (CF) globally, research & development activities undertaken by key players, and favorable initiatives undertaken by nonprofit organizations are expected to boost the market over the forecast period. The rising prevalence of CF indicates the rising demand for treatment alternatives, thereby uplifting the market. The key players operating in this market in collaboration with nonprofit organizations focus on the development of novel therapeutics for treatment. Some of the drugs that...
  9. スマート医療機器の世界市場分析：診断装置、モニタリング装置、治療装置
    GVIEW708018 / Grand View Research / 2017年7月 / Grand View Research（米国）が発行した本調査レポートでは、スマート医療機器の世界市場について調査・分析し、スマート医療機器の世界市場動向、スマート医療機器の世界市場規模、市場予測、セグメント別スマート医療機器市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。...The global smart medical devices market is expected to reach USD 24.46 billion by 2025, according to a new report by Grand View Research, Inc. The increasing adoption of smartphones is observed as a major factor driving market growth. In addition, the technological advancement and the rising awareness and focus on fitness is driving the market. The increasing demand for wireless and smartphone compatible devices which is enhancing the diagnosis and makes accurate detection is making it convenient for patients to monitor their health anywhere and save the result on the connected device, is additionally driving the market. Diagnostic and...
  10. 心血管系医療デバイスの世界市場：心臓律動管理、補綴装置、インターベンショナル心血管用製品、モニタリング、診断機器
    VGAIN5112514 / visiongain / 2015年11月 / 当調査レポートでは、心血管系医療デバイスの世界市場について調査・分析し、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・心血管系医療デバイスの世界市場 　（市場規模予測、市場の成長要因・阻害要因など） ・心血管系医療デバイスの世界市場：デバイス種類別市場分析 ・心血管系医療デバイスの世界市場：地域別市場分析、市場規模予測 ・心血管系医療デバイスの世界市場：環境分析 ・心血管系医療デバイスの世界市場：専門家の見解 ・心血管系医療デバイスの世界市場：主要企業分析...Cardiovascular medical devices – how to discover that technology’s commercial potential What is the future of devices for the human circulatory system? In visiongain’s new study you discover technological and commercial predictions from 2015. See what is possible. That way you stay ahead for data, benefiting your work and authority. For those medical devices you explore sales results, developments, opportunities and revenue forecasts to 2025. Succeed through discovering companies’ trends, progress and potential gains. Forecasts and other analysis showing potential revenues from those cardio products Discover how to help your reputation for commercial insight. Our study’s purpose is showing you...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆